Big Pharma profiteering gone wild: $1,000-a-pill Hepatitis drug in USA sells for less than $10 in Egypt
by Mike Adams
NaturalNews.com
Wednesday, March 26, 2014
The financial raping of America by Big Pharma has just achieved a new milestone with the impending launch of a Hepatitis C drug that costs $1,000 a pill. If you’ve ever wondered why U.S. health care is so unaffordable and inaccessible — and why health insurance costs are bankrupting businesses and municipalities across the nation — this is exactly why. The same drug that sells for $1,000 a pill in the USA — named “Sovaldi” — sells for just $10 in Egypt, or 1/100th the USA price.
Drug companies are, of course, granted FDA-enforced monopolies on the treatment of anything considered a “disease.” As such, drugs are pushed into the marketplace at monopoly prices. Because if you’re the CEO of Gilead Sciences, Inc., makers of the Sovaldi drug to be sold at $1,000 a pill, your job is to maximize revenues by any means necessary. When you’re handed a monopoly by the FDA, the strategy for achieving that is simple: Raise the price to whatever you can get away with, then bill the insurance companies, Medicare and Medicaid for $100, $500 or even $1,000 a pill.
100,000% mark-up?
The Rest…HERE
